28.05.2019 • NewsBoehringer IngelheimDede Willams

Boehringer Ingelheim Expanding in Mexico

Boehringer Ingelheim Expanding in Mexico (c) Boehringer Ingelheim
Boehringer Ingelheim Expanding in Mexico (c) Boehringer Ingelheim

German drugmaker Boehringer Ingelheim is planning to invest around 1.6 billion pesos (about $84 million) at its three manufacturing sites in Mexico over the next two years, with the aim of boosting production at all three.

The first and biggest project with be to lift output at its Xochimilco tableting site for diabetic drugs near Mexico City, taking output capability to 2.5 billion tablets annually in 2028 from about 1.6 billion units currently.

 Boehringer said the expansion will allow it to increase exports to the US as well as Argentina, Colombia and Brazil.  

Last year, the drugmaker began construction on a $100 million R&D and manufacturing facility in Germany, where it plans to develop and manufacture more complex tablets for global launches. Simultaneously, it is moving production of what it calls older, less complex drugs to other worldwide sites.

 

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.